As conclusion, a gene‐therapy approach to re‐express GATA4 or protein therapy with IL‐13 might be evaluated as therapeutic strategies to enhance myocardial regeneration in pediatric patients with heart disease or even in adult patients after MI in the future. Here, IL13 is linked to myocardial infarction.